Over 700 delegates attended the Fertility 2018 Conference in Liverpool last week and were invited to join our team at the CooperSurgical stand to find out more about our products, services, and training events.
New Biopsy Support Packages
We were overwhelmed by the interest in our four new Biopsy Support Packages. Ranging from Bronze to Platinum, these packages have been tailored to meet varied clinic needs. We offer full support throughout to ensure implementation of an efficient clinical PGS/PGD service is as easy as possible.
Mike Whalley, PhD, Managing Director for CooperSurgical UK commented “Many clinics are either thinking about offering PGS/PGD to their patients or are in the middle of the process, and the four tiers of support offer them the solution to find the perfect match for their needs.
“The packages do not just cover the equipment, consumables and tests required, but also include practical support in the lab by offering biopsy training, advice on starting license applications, collating documentation and helping clinics to get the service implemented successfully. We really want to support customers from the beginning to end and make implementing a PGS/PGD service not as insurmountable as many first think”.
Embryo biopsy top tips and troubleshooting
Embryo biopsy was a hot topic at the show, and our experts Colleen Lynch, PhD, and Dave Morroll, PhD, shared some of their top tips and tricks at our stand. Using the RI Integra 3TM micromanipulator and RI Saturn 5TM laser system, Dave gave a hands-on demonstration showing how a combination of laser and mechanical techniques can be used to retrieve a sample for genetic testing with minimal stress to the embryo.
Understanding mosaicisms in embryos
David Chrimes, PhD, from CooperGenomicsSM gave a talk covering how mosaicism occurs, as well as explaining how we detect and report mosaicism based on the latest clinical evidence around implantation and ongoing pregnancy rates.
Real-world experience with GM-CSF culture media
Melanie Evison, Senior Embryologist at the Nuffield Health Woking Hospital, UK, joined us at the stand to give an account of their positive experiences working with EmbryoGen, ORIGIO’s media containing the recombinant human cytokine GM-CSF for cleavage stage embryos.
Recommended for patients experiencing recurrent implantation failure or miscarriage, Melanie explained why they are now advising patients to have single embryo transfers to balance the increase in multiple pregnancy rate observed since introducing the media for this poor prognosis group.
Did you manage to get your hands on a copy of our brand new newsletter, ART Scientific, at our stand? The first edition, authored by our Director of Embryology, Steve Fleming, PhD, features a review of benchmarking ART laboratories, staff and clinic performance.
If you didn’t, don’t worry! Click here to subscribe and ensure you receive the next edition straight in your inbox.
Tracking lab KPIs with RI WitnessTM analytics
This topic generated a great deal of interest and sparked lots of conversation at the stand. While it is commonly known that RI Witness is an ART management system designed to help prevent potential errors and manage activities within the lab, did you know that the analytics function can be harnessed to track performance indicators (PIs)?
So if you haven’t had a chance to read it yet, click here to make sure you don’t miss out.